If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
Related Posts
Popular News
-
Is Berkshire Hathaway Class B Stock a Good Buy? • Benzinga
-
How to Contact Hilton Customer Service
-
Alex Zozos: Tokenized securities are classified as securities, the SEC’s evolving role in on-chain trading, and how blockchain enhances trading efficiency
-
Thousands of flights canceled ahead of U.S. winter storm
-
‘Click to cancel’ bills in Congress target hard-to-undo subscriptions
Latest News
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.
US Lawmakers Introduce Bill to Crack Down on Prediction Markets War Bets
Two Democratic lawmakers in the US Congress have introduced legislation in response to “government corruption” over bets on prediction markets...
The Amazon Echo Show 11 Is $50 Off Right Now
We may earn a commission from links on this page. Deal pricing and availability subject to change after time of...
US stocks open higher as Dow jumps while crypto equities struggle for direction
U.S. stocks opened higher on Tuesday, extending a risk‑on regime across the Dow, S&P 500 and Nasdaq even as crypto‑linked...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.